3939 BroadwayNew York, NY 10032
Overview of Dr. Milner
Dr. Joshua Milner is an allergist/immunologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Albert Einstein College of Medicine and has been in practice 26 years. He is one of 26 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 72 doctors at New York-Presbyterian Hospital who specialize in Allergy & Immunology. He also speaks multiple languages, including Hebrew and Spanish. He has more than 100 publications and over 500 citings.
Education & Training
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2003 - 2005
Children's National HospitalResidency, Pediatrics, 2000 - 2003
Albert Einstein College of MedicineClass of 2000
Certifications & Licensure
NY State Medical License 2019 - 2027
DC State Medical License 2003 - 2020
Clinical Trials
- A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis Start of enrollment: 2010 Apr 14
Publications & Presentations
PubMed
- Targeted deep sequencing identifies mosaicism in patients with immune dysregulation.Elizabeth G Schmitz, Alexander J Paul, Rajarshi Ghosh, Nermina Saucier, Ana Kolicheski
The Journal of Allergy and Clinical Immunology. 2026-05-01 - Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.Alexandra F Freeman, Chen Wang, Amanda Urban, Iris Martin, Lauren Dang
The Journal of Allergy and Clinical Immunology. 2026-04-28 - School Difficulties and Long COVID in Children and Adolescents.Harrison T Reeder, Lawrence C Kleinman, Melissa S Stockwell, Tanayott Thaweethai, Deepti B Pant
Academic Pediatrics. 2026-04-03
Journal Articles
- Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York CitySteven G Kernie, Joshua D Milner, JAMA
Authored Content
- Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene ExpressionJune 2018
Press Mentions
Research Explores Genetics Underlying Immune System DisordersAugust 22nd, 2025- Pharming Group to Host Webcast on Findings of a New Study Published in Cell Advancing Functional Classification of Variants of Uncertain Significance (VUS) to Improve APDS DiagnosisJune 24th, 2025
- The GUARDIAN Study: Transforming Newborn Health Through Expanded Genetic Screening for Rare DisordersApril 23rd, 2025
Grant Support
- Systematic variant-to-pathway, phenotype, and precision treatment response evaluation in genetic disorders of the immune system (GDIS)COLUMBIA UNIVERSITY HEALTH SCIENCES2026–2031
- Systematic variant-to-pathway, phenotype, and precision treatment response evaluation in genetic disorders of the immune system (GDIS)COLUMBIA UNIVERSITY HEALTH SCIENCES2026–2031
- Systematic variant-to-pathway, phenotype, and precision treatment response evaluation in genetic disorders of the immune system (GDIS)COLUMBIA UNIVERSITY HEALTH SCIENCES2026–2031
- New York Regional Inborn Errors of Immunity Resource Initiative League (NY-ROYAL)COLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
- Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic diseaseHENRY M. JACKSON FDN FOR THE ADV MIL/MED2023–2028
Other Languages
- Hebrew, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
